OIS@SECO 2019

FEBRUARY 21, 2019
NEW ORLEANS, LA

OIS has expanded our mission of highlighting innovations for the comprehensive ophthalmic community by launching the inaugural OIS@SECO.

OIS@SECO 2019
OIS San Diego

MAY 2, 2019
SAN DIEGO, CA

OIS unites over 500 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASCRS
OIS Chicago

JULY 25, 2019
CHICAGO, IL

OIS unites 300 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@ASRS 2019
OIS San Francisco

OCTOBER 10, 2019
SAN FRANCISCO, CA

OIS unites over 1,000 industry, entrepreneurial and clinical leaders to collaborate on the development and commercialization of innovative drugs and devices to address unmet clinical needs.

OIS@AAO

Facilitating meaningful interactions and the exchange of information between industry and clinical leaders since 2009.

LATEST NEWS

Keeping an "Eye on Innovation" Through News & Analysis

Nicox Patiently Pursues Moves to Build Value

Nicox Patiently Pursues Moves to Build Value

Nicox SA has taken several steps in the past few months to increase shareholder value. It has two product candidates headed toward Phase II trials, ...
Can 2019 Be ‘Transformative’ for AGTC?

After XLRS Gene Therapy Disappoints, AGTC Looks to ‘Transformative Year’

Since announcing disappointing clinical trial results for one of its lead ophthalmic gene therapy candidates and the termination of its collaboration agreement with Biogen, Applied ...
OIS Index Follows the Stock Market Lower in December

OIS Index Follows the Stock Market Lower in December

The OIS Index declined 11% in December, marking the fourth month in a row in which ophthalmic stocks lost value. For the month, the overall ...
Will Changes in the FDA’s 510(k) Process Be Good for Innovators?

Will Changes in the FDA’s 510(k) Process Be Good for Innovators?

Key players in the medical device industry, including one major player in ophthalmology, have issued mixed reviews in response to the Food and Drug Administration’s ...
Alcon Executives Lay Out a Road Map for after the Spin-off

Alcon Executives Lay Out a Road Map for after the Spin-off

With a management team experienced in healthcare and ophthalmology, and market trends like aging increasing the need for ophthalmic care and a rich pipeline of ...
Chasing Presbyopia Utopia

Chasing Presbyopia Utopia: Four Innovators and Their Search for Ophthalmology’s ‘Holy Grail’

The numbers can be overwhelming: 1.8 billion people globally were living with presbyopia in 2015, 826 million of whom had near vision impairment because they ...

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.